Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
10.1021/jf071328f J
Only one trial (Talari et al., 2019) mentioned that the researchers and participants were not blinded to the allocation concealment, thereby resulting in a high risk of bias
To address this question, CAROLINA : Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes is ongoing (NCT01243424)
Best JH, Hoogwerf BJ, Herman WH, Pelletier EM, Smith DB, Wenten M, Hussein MA: Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database
Likewise, consuming kale juice for six weeks had a different impact based on GST subtype, especially in the vitamin C levels and DNA damage, with the GSTM1 null genotype experiencing the best impact from the kale juice
US$ 26.96
US$ 23.88
US$ 24.51
US$ 28.39
US$ 29.92
US$ 27.28
